XML 24 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2021 $ 11,244 $ 57 $ 27,561 $ (10,529) $ (2,683) $ (4,128) $ 10,278 $ 966
Beginning balance, shares at Dec. 31, 2021   1,209            
Net Income (loss) (2,499)     (2,446)     (2,446) (53)
Other comprehensive income (loss) (270)       (154)   (154) (116)
Issuance of Shares, value 1   1       1  
Issuance of Shares, shares   8            
Stock-based compensation expense 124   124       124  
Transactions with non-controlling interests (2)             (2)
Ending balance at Dec. 31, 2022 8,598 $ 57 27,688 (12,975) (2,838) (4,128) 7,804 794
Ending balance, shares at Dec. 31, 2022   1,217            
Net Income (loss) (615)     (559)     (559) (56)
Other comprehensive income (loss) 91       141   141 (50)
Issuance of Shares, shares   10            
Stock-based compensation expense 121   121       121  
Dividend to non-controlling interests (68)             (68)
Ending balance at Dec. 31, 2023 8,126 $ 57 27,807 (13,534) (2,697) (4,128) 7,506 620
Ending balance, shares at Dec. 31, 2023   1,227            
Net Income (loss) (1,959)     (1,639)     (1,639) (320)
Other comprehensive income (loss) (508)       (447)   (447) (61)
Issuance of Shares, value 1 $ 1         1  
Issuance of Shares, shares   13            
Stock-based compensation expense 123   123       123  
Dividend to non-controlling interests (18)             (18)
Proceeds from exercise of options 19   19       19  
Purchase of shares from non-controlling interests (64)   (45)   (3)   (48) (16)
Reclassification to redeemable non-controlling interests (340)   (142)       (142) (198)
Ending balance at Dec. 31, 2024 $ 5,380 $ 58 $ 27,764 $ (15,173) $ (3,148) $ (4,128) $ 5,373 $ 7
Ending balance, shares at Dec. 31, 2024   1,240